Byetta Lawsuit News: New Order Issued in Federal Incretin Mimetics...

Hundreds of Byetta lawsuits and other product liability claims involving incretin mimetic diabetes drugs are currently pending in the federal litigation underway in California.(PRWeb December 21, 2014)Read the full story at http://www.prweb.com/releases/byetta-lawsuit/byetta-pancreatic-cancer/prweb12409444.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news